(KMI) Kinder Morgan - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US49456B1017
Stock: Pipelines, Terminals, CO2, Gas, Liquids
Total Rating 54
Risk 62
Buy Signal -0.02
| Risk 5d forecast | |
|---|---|
| Volatility | 21.5% |
| Relative Tail Risk | -5.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 20.54 |
| Character TTM | |
|---|---|
| Beta | 0.424 |
| Beta Downside | 0.249 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.40% |
| CAGR/Max DD | 1.87 |
EPS (Earnings per Share)
Revenue
Description: KMI Kinder Morgan March 05, 2026
Kinder Morgan, Inc. (KMI) is a North American energy infrastructure company. It operates across four segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2.
The Natural Gas Pipelines segment manages a network of pipelines, storage, and processing facilities for natural gas and natural gas liquids. This sector is characterized by long-term contracts and regulated tariffs.
The Products Pipelines segment transports refined petroleum products and crude oil, along with associated terminal operations. Pipeline operators often benefit from stable fee-based revenues.
The Terminals segment provides storage and handling services for various liquid and bulk commodities, including fuels and chemicals. Terminal operations are critical for connecting different modes of transport and facilitating trade.
The CO2 segment focuses on CO2 production, transportation, and marketing for enhanced oil recovery, a method used to extend the life of mature oil fields. This segment also includes interests in oil fields and gasoline processing plants.
For more detailed financial analysis and performance metrics, further research on platforms like ValueRay can be beneficial.
Headlines to watch out for
- Natural gas pipeline volumes directly impact revenue
- Commodity price fluctuations affect CO2 segment profitability
- Regulatory changes for pipelines create compliance costs
- Interest rate changes influence debt financing expenses
- Industrial and consumer energy demand drives throughput volumes
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 3.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.59 > 1.0 |
| NWC/Revenue: -9.25% < 20% (prev -17.12%; Δ 7.87% < -1%) |
| CFO/TA 0.08 > 3% & CFO 5.98b > Net Income 3.06b |
| Net Debt (32.28b) to EBITDA (7.48b): 4.32 < 3 |
| Current Ratio: 0.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.23b) vs 12m ago 0.23% < -2% |
| Gross Margin: 43.66% > 18% (prev 0.37%; Δ 4.33k% > 0.5%) |
| Asset Turnover: 23.23% > 50% (prev 21.11%; Δ 2.12% > 0%) |
| Interest Coverage Ratio: 2.79 > 6 (EBITDA TTM 7.48b / Interest Expense TTM 1.80b) |
Altman Z'' -0.37
| A: -0.02 (Total Current Assets 2.75b - Total Current Liabilities 4.32b) / Total Assets 74.55b |
| B: -0.14 (Retained Earnings -10.18b / Total Assets 74.55b) |
| C: 0.07 (EBIT TTM 5.03b / Avg Total Assets 72.98b) |
| D: -0.24 (Book Value of Equity -10.11b / Total Liabilities 42.10b) |
| Altman-Z'' Score: -0.37 = B |
Beneish M -3.11
| DSRI: 1.01 (Receivables 1.71b/1.51b, Revenue 16.95b/15.07b) |
| GMI: 0.84 (GM 43.66% / 36.67%) |
| AQI: 1.00 (AQ_t 0.43 / AQ_t-1 0.43) |
| SGI: 1.12 (Revenue 16.95b / 15.07b) |
| TATA: -0.04 (NI 3.06b - CFO 5.98b) / TA 74.55b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of KMI shares?
As of March 16, 2026, the stock is trading at USD 33.39 with a total of 10,494,334 shares traded.
Over the past week, the price has changed by +0.27%, over one month by +3.92%, over three months by +26.17% and over the past year by +25.33%.
Over the past week, the price has changed by +0.27%, over one month by +3.92%, over three months by +26.17% and over the past year by +25.33%.
Is KMI a buy, sell or hold?
Kinder Morgan has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy KMI.
- StrongBuy: 8
- Buy: 3
- Hold: 8
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.3 | -0.2% |
| Analysts Target Price | 33.3 | -0.2% |
KMI Fundamental Data Overview March 14, 2026
P/E Trailing = 24.3723
P/E Forward = 24.5098
P/S = 4.386
P/B = 2.3817
P/EG = 3.9247
Revenue TTM = 16.95b USD
EBIT TTM = 5.03b USD
EBITDA TTM = 7.48b USD
Long Term Debt = 30.78b USD (from longTermDebt, last quarter)
Short Term Debt = 1.27b USD (from shortTermDebt, last quarter)
Debt = 32.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.28b USD (from netDebt column, last quarter)
Enterprise Value = 106.61b USD (74.29b + Debt 32.39b - CCE 63.0m)
Interest Coverage Ratio = 2.79 (Ebit TTM 5.03b / Interest Expense TTM 1.80b)
EV/FCF = 29.61x (Enterprise Value 106.61b / FCF TTM 3.60b)
FCF Yield = 3.38% (FCF TTM 3.60b / Enterprise Value 106.61b)
FCF Margin = 21.24% (FCF TTM 3.60b / Revenue TTM 16.95b)
Net Margin = 18.03% (Net Income TTM 3.06b / Revenue TTM 16.95b)
Gross Margin = 43.66% ((Revenue TTM 16.95b - Cost of Revenue TTM 9.55b) / Revenue TTM)
Gross Margin QoQ = 67.90% (prev 32.71%)
Tobins Q-Ratio = 1.43 (Enterprise Value 106.61b / Total Assets 74.55b)
Interest Expense / Debt = 1.36% (Interest Expense 442.0m / Debt 32.39b)
Taxrate = 21.76% (284.0m / 1.30b)
NOPAT = 3.93b (EBIT 5.03b * (1 - 21.76%))
Current Ratio = 0.64 (Total Current Assets 2.75b / Total Current Liabilities 4.32b)
Debt / Equity = 1.04 (Debt 32.39b / totalStockholderEquity, last quarter 31.16b)
Debt / EBITDA = 4.32 (Net Debt 32.28b / EBITDA 7.48b)
Debt / FCF = 8.97 (Net Debt 32.28b / FCF TTM 3.60b)
Total Stockholder Equity = 30.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.19% (Net Income 3.06b / Total Assets 74.55b)
RoE = 9.92% (Net Income TTM 3.06b / Total Stockholder Equity 30.82b)
RoCE = 8.16% (EBIT 5.03b / Capital Employed (Equity 30.82b + L.T.Debt 30.78b))
RoIC = 6.22% (NOPAT 3.93b / Invested Capital 63.24b)
WACC = 5.53% (E(74.29b)/V(106.67b) * Re(7.48%) + D(32.39b)/V(106.67b) * Rd(1.36%) * (1-Tc(0.22)))
Discount Rate = 7.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.09%
[DCF] Terminal Value 86.51% ; FCFF base≈3.37b ; Y1≈3.43b ; Y5≈3.76b
[DCF] Fair Price = 35.86 (EV 112.05b - Net Debt 32.28b = Equity 79.77b / Shares 2.22b; r=5.90% [WACC]; 5y FCF grow 1.58% → 2.90% )
EPS Correlation: 32.69 | EPS CAGR: 8.22% | SUE: 2.02 | # QB: 1
Revenue Correlation: -34.84 | Revenue CAGR: 0.44% | SUE: 0.23 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.30 | Chg7d=-0.001 | Chg30d=+0.003 | Revisions Net=-3 | Analysts=11
EPS current Year (2026-12-31): EPS=1.36 | Chg7d=+0.000 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=+5.0% | Growth Revenue=+4.4%
EPS next Year (2027-12-31): EPS=1.46 | Chg7d=-0.004 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+7.2% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.8% (Discount Rate 7.9% - Earnings Yield 4.1%)
[Growth] Growth Spread = +0.2% (Analyst 4.1% - Implied 3.8%)
P/E Forward = 24.5098
P/S = 4.386
P/B = 2.3817
P/EG = 3.9247
Revenue TTM = 16.95b USD
EBIT TTM = 5.03b USD
EBITDA TTM = 7.48b USD
Long Term Debt = 30.78b USD (from longTermDebt, last quarter)
Short Term Debt = 1.27b USD (from shortTermDebt, last quarter)
Debt = 32.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.28b USD (from netDebt column, last quarter)
Enterprise Value = 106.61b USD (74.29b + Debt 32.39b - CCE 63.0m)
Interest Coverage Ratio = 2.79 (Ebit TTM 5.03b / Interest Expense TTM 1.80b)
EV/FCF = 29.61x (Enterprise Value 106.61b / FCF TTM 3.60b)
FCF Yield = 3.38% (FCF TTM 3.60b / Enterprise Value 106.61b)
FCF Margin = 21.24% (FCF TTM 3.60b / Revenue TTM 16.95b)
Net Margin = 18.03% (Net Income TTM 3.06b / Revenue TTM 16.95b)
Gross Margin = 43.66% ((Revenue TTM 16.95b - Cost of Revenue TTM 9.55b) / Revenue TTM)
Gross Margin QoQ = 67.90% (prev 32.71%)
Tobins Q-Ratio = 1.43 (Enterprise Value 106.61b / Total Assets 74.55b)
Interest Expense / Debt = 1.36% (Interest Expense 442.0m / Debt 32.39b)
Taxrate = 21.76% (284.0m / 1.30b)
NOPAT = 3.93b (EBIT 5.03b * (1 - 21.76%))
Current Ratio = 0.64 (Total Current Assets 2.75b / Total Current Liabilities 4.32b)
Debt / Equity = 1.04 (Debt 32.39b / totalStockholderEquity, last quarter 31.16b)
Debt / EBITDA = 4.32 (Net Debt 32.28b / EBITDA 7.48b)
Debt / FCF = 8.97 (Net Debt 32.28b / FCF TTM 3.60b)
Total Stockholder Equity = 30.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.19% (Net Income 3.06b / Total Assets 74.55b)
RoE = 9.92% (Net Income TTM 3.06b / Total Stockholder Equity 30.82b)
RoCE = 8.16% (EBIT 5.03b / Capital Employed (Equity 30.82b + L.T.Debt 30.78b))
RoIC = 6.22% (NOPAT 3.93b / Invested Capital 63.24b)
WACC = 5.53% (E(74.29b)/V(106.67b) * Re(7.48%) + D(32.39b)/V(106.67b) * Rd(1.36%) * (1-Tc(0.22)))
Discount Rate = 7.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.09%
[DCF] Terminal Value 86.51% ; FCFF base≈3.37b ; Y1≈3.43b ; Y5≈3.76b
[DCF] Fair Price = 35.86 (EV 112.05b - Net Debt 32.28b = Equity 79.77b / Shares 2.22b; r=5.90% [WACC]; 5y FCF grow 1.58% → 2.90% )
EPS Correlation: 32.69 | EPS CAGR: 8.22% | SUE: 2.02 | # QB: 1
Revenue Correlation: -34.84 | Revenue CAGR: 0.44% | SUE: 0.23 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.30 | Chg7d=-0.001 | Chg30d=+0.003 | Revisions Net=-3 | Analysts=11
EPS current Year (2026-12-31): EPS=1.36 | Chg7d=+0.000 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=+5.0% | Growth Revenue=+4.4%
EPS next Year (2027-12-31): EPS=1.46 | Chg7d=-0.004 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+7.2% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.8% (Discount Rate 7.9% - Earnings Yield 4.1%)
[Growth] Growth Spread = +0.2% (Analyst 4.1% - Implied 3.8%)